chr11-106009714-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000301919.9(MSANTD4):āc.859A>Gā(p.Met287Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000301919.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSANTD4 | NM_032424.3 | c.859A>G | p.Met287Val | missense_variant | 3/3 | ENST00000301919.9 | NP_115800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSANTD4 | ENST00000301919.9 | c.859A>G | p.Met287Val | missense_variant | 3/3 | 1 | NM_032424.3 | ENSP00000304713.4 | ||
MSANTD4 | ENST00000529805.1 | n.35A>G | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251384Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135876
GnomAD4 exome AF: 0.000148 AC: 217AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.000155 AC XY: 113AN XY: 727246
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.859A>G (p.M287V) alteration is located in exon 3 (coding exon 2) of the MSANTD4 gene. This alteration results from a A to G substitution at nucleotide position 859, causing the methionine (M) at amino acid position 287 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at